FDA Inspection 884835 — Abbott Molecular, Inc.

Abbott Molecular, Inc. — FEI 3005248192

The FDA completed an inspection of Abbott Molecular, Inc. on July 11, 2014 in Des Plaines, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 11, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Des Plaines, IL (United States)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
419121 CFR 806.10(a)(1)Report of risk to health
53721 CFR 820.70(a)Production processes